Sangamo Therapeutics, Inc (SGMOQ): Depreciation & Amortization
$3.96M
Year ended 2025-12-31
$3.66M
Trailing 12 months to 2026-03-31
-31.1%
3-year compound annual growth
-7.0%
5-year compound annual growth
+14.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.96M | -22.4% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $5.11M | -66.1% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $15.06M | +24.4% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | $12.11M | +28.3% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $9.44M | +66.1% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $5.68M | +44.6% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $3.93M | +66.6% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $2.36M | +57.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $1.50M | +50.3% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $997.0K | +0.9% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $988.0K | +80.0% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $549.0K | -3.5% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $569.0K | -13.8% | 2016-02-18, From 2013-01-01 |
| 2012-12-31 | $660.0K | +2.2% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $646.0K | -4.4% | 2014-02-24, From 2011-01-01 |
| 2010-12-31 | $676.0K | +18.2% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $572.0K | n/a | 2012-02-23, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $3.96M | -22.4% |
| Kymera Therapeutics, Inc. (KYMR) | 2025-12-31 | $8.31M | +12.7% |
| C4 Therapeutics, Inc. (CCCC) | 2025-12-31 | $1.96M | +7.8% |
| X4 Pharmaceuticals, Inc (XFOR) | 2025-12-31 | $1.28M | +60.4% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $1.47M | -56.9% |
| Scilex Holding Co (SCLX) | 2025-12-31 | $4.62M | +14.3% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $1.38M | -16.0% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $11.68M | -19.8% |
| Alector, Inc. (ALEC) | 2025-12-31 | $5.72M | +5.8% |
Compare SGMOQ, KYMR, CCCC, XFOR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗